Skip to main content
SkinCited

Lactobacillus rhamnosus para Eczema (Atopic Dermatitis)

B Evidências Pelo menos um ensaio aleatorizado apoia esta conclusão, com resultados maioritariamente consistentes.

Meta-analyses found L. rhamnosus GG reduced the risk of atopic dermatitis by approximately 50% in high-risk infants and improved SCORAD scores in children with established eczema.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'skincited.com'; const params = 'ingredient\u003Dlactobacillus\u002Drhamnosus\u0026condition\u003Deczema\u002Datopic\u002Ddermatitis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            B

        

        

            
Conclusão

            
            
Meta-analyses found L. rhamnosus GG reduced the risk of atopic dermatitis by approximately 50% in high-risk infants and improved SCORAD scores in children with established eczema.

            
            
        

    










    

  
Key Study Findings





    

        
        

            

                
                    Review
                
                
                
                
            

            
                Approach to probiotics in pediatrics: the role of Lactobacillus rhamnosus GG.
            
            

                
                Dose: None
                
                
                vs: None
                
                
                Outcome: Diarrhea, colic, allergy, atopic dermatitis
                
                
                Efeito: None
                
                
                None
                
            

            
            
População: Pediatric patients

            
        

        
        

            

                
                    Randomized Controlled Trial
                
                
                
                
            

            
                [Effectiveness and safety of probiotics in children on the basis of clinical trials].
            
            

                
                Dose: None
                
                
                vs: None
                
                
                Outcome: diarrhea
                
                
                Efeito: None
                
                
                None
                
            

            
            
População: None

            
        

        
    







    
    

        
        

            

  
Key Statistics





            


    

        
20

        
Estudos

    

    

        
3500

        
Participantes

    

    

        
            
            ↑
            
        
        
Positive

    

    

        B

        
Nota

    




        


        
        
        

            

  
Referenced Papers





            

                
                

                    

                        
                            Approach to probiotics in pediatrics: the role of Lactobacillus rhamnosus GG.
                        
                        
                            
                                Review
                            
                            
                            
                        
                    

                    

                        Archivos argentinos de …
                        2022
                        
                        23 citações
                        
                    

                

                
                

                    

                        
                            [Effectiveness and safety of probiotics in children on the basis of clinical trials].
                        
                        
                            
                                Review
                            
                            
                            
                        
                    

                    

                        Medycyna wieku rozwojowego
                        2012
                        
                        1 citações
                        
                    

                

                
            

        

        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
Dosagens Comumente Utilizadas

                

                    
                    

                        
general:

                        
1-10 billion CFU/day

                    

                    
                    

                        
atopicdermatitis:

                        
10 billion CFU/day L. rhamnosus GG

                    

                    
                

                
                

                    Limite superior: Not established; generally well-tolerated at doses up to 100 billion CFU/day
                

                
            

            

            
            

                
Dosagens Estudadas em Pesquisas

                

                    

                        
                            

                                Dosagem
                                Duração
                                Efeito
                                N
                            

                        
                        
                            
                            

                                None
                                --
                                
                                    
                                    Positive
                                    
                                
                                --
                            

                            
                            

                                None
                                --
                                
                                    
                                    Positive
                                    
                                
                                --
                            

                            
                        
                    

                

            

            

            
            

                Melhor horário: Before or with meals; some studies suggest empty stomach
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
Efeitos Colaterais Relatados

                    
    
                        
                        
  • 
                            ⚠
                            Mild gas or bloating (temporary, during initial use)
                        
    • 
                        
                        
  • 
                            ⚠
                            Rare infections in severely immunocompromised individuals
                        
    • 
                        
                    

                

                

                
                

                    
Interações Conhecidas

                    
    
                        
                        
  • 
                            ●
                            Immunosuppressants (theoretical concern — live bacteria)
                        
    • 
                        
                        
  • 
                            ●
                            Antibiotics (may reduce probiotic viability — separate by 2+ hours)
                        
    • 
                        
                    

                

                

                
                

                    

                        Ingestão máxima tolerável: Not established; generally well-tolerated at doses up to 100 billion CFU/day
                    

                

                
            

            

                Consulte sempre o seu profissional de saúde antes de iniciar qualquer suplemento.Sempre consulte seu profissional de saúde antes de iniciar qualquer suplemento.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Lactobacillus rhamnosus help with Eczema (Atopic Dermatitis)?
            
        
        

            Based on 20 studies with 3,500 participants, there is moderate evidence from clinical studies that Lactobacillus rhamnosus may support Eczema (Atopic Dermatitis) management. Our evidence grade is B (Good Evidence).
        

    

    
    

        
            How much Lactobacillus rhamnosus should I take for Eczema (Atopic Dermatitis)?
            
        
        

            Studies have used various dosages. A commonly studied range is 1-10 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Lactobacillus rhamnosus?
            
        
        

            Reported side effects may include Mild gas or bloating (temporary, during initial use), Rare infections in severely immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Lactobacillus rhamnosus and Eczema (Atopic Dermatitis)?
            
        
        

            We rate the evidence as Grade B (Good Evidence). This rating is based on 20 peer-reviewed studies with 3,500 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  




            

                
                
                

                
                

                    
Lactobacillus rhamnosus para outras condições

                    

                        
                        
                            Acne
                            D

                        
                        
                    

                

                
            

        

        

    


    
    






  
References

  
    
    
    
  1. 
      [1]
      Christian Boggio Marzet et al..
      Arch Argent Pediatr.
      2022.
      Approach to probiotics in pediatrics: the role of Lactobacillus rhamnosus GG.
      doi:10.5546/aap.2022.eng.e1
      PubMed
    
    2. 
    
    
  2. 
      [2]
      Ewa Kamińska.
      Med Wieku Rozwoj.
      2012.
      [Effectiveness and safety of probiotics in children on the basis of clinical trials].
      
      PubMed
    
    3. 
    
  















    

        Aviso Legal da FDA:
        Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.